Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06372865 in Generalized Anxiety Disorder
NCT02310568Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Nov 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of darigabat in generalized anxiety disorder (GAD), sponsored by Pfizer. Started Nov 2014; status: terminated.
02
Drugs
darigabat
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT02310568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02310568.